These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 28373458)

  • 21. PTPRJ haplotypes and colorectal cancer risk.
    Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TP53 alterations and colorectal cancer predisposition in south Indian population: a case-control study.
    Singamsetty GK; Malempati S; Bhogadhi S; Kondreddy R; Govatati S; Tangudu NK; Govatati S; kuraganti AK; Bhanoori M; Kassetty K
    Tumour Biol; 2014 Mar; 35(3):2303-11. PubMed ID: 24158910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk.
    Frank B; Hoeft B; Hoffmeister M; Linseisen J; Breitling LP; Chang-Claude J; Brenner H; Nieters A
    Carcinogenesis; 2011 Feb; 32(2):190-6. PubMed ID: 21047993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF polymorphisms may be associated with susceptibility to colorectal cancer: a case-control study.
    Antonacopoulou AG; Kottorou AE; Dimitrakopoulos FI; Triantafyllia V; Marousi S; Koutras A; Kalofonos HP
    Cancer Biomark; 2011; 10(5):213-7. PubMed ID: 22699782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A related analysis for alpha, beta fibrinogen gene haplotypes and nucleotide polymorphisms associated with the ischemic stroke in Hainan Han population].
    Liang L; Sun C; Liao XP; Xiao F; Chen XD; Huang SX; Tang XL; Wen GQ; Long ZG; Wang XY; Liu GX; Cheng S; Cai WW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):316-9. PubMed ID: 16767673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA.
    Gemignani F; Moreno V; Landi S; Moullan N; Chabrier A; Gutiérrez-Enríquez S; Hall J; Guino E; Peinado MA; Capella G; Canzian F
    Oncogene; 2004 Mar; 23(10):1954-6. PubMed ID: 14647431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between TNF-α-308G>A and -238G>A gene polymorphisms and TNF-α serum levels in Mexican colorectal cancer patients.
    Gutiérrez-Hurtado IA; Puebla-Pérez AM; Delgado-Saucedo JI; Figuera LE; Zúñiga-González GM; Gomez-Mariscal K; Ronquillo-Carreón CA; Gallegos-Arreola MP
    Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population.
    Yang Y; Xiao Z; Chen W; Sang H; Guan Y; Peng Y; Zhang D; Gu Z; Qian M; He G; Qin W; Li D; Gu N; He L
    Neurosci Lett; 2004 Oct; 369(2):126-31. PubMed ID: 15450681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between the functional polymorphisms in the ABCB1 transporter gene and colorectal cancer risk: a case-control study in Turkish population.
    Özhan G; Kara M; Sari FM; Yanar HT; Ercan G; Alpertunga B
    Toxicol Mech Methods; 2013 May; 23(4):235-9. PubMed ID: 23193993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A haplotype variation affecting the mitochondrial transportation of hMYH protein could be a risk factor for colorectal cancer in Chinese.
    Chen H; Xu L; Qi Q; Yao Y; Zhu M; Wang Y
    BMC Cancer; 2008 Sep; 8():269. PubMed ID: 18811933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
    Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
    Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic.
    Pardini B; Kumar R; Naccarati A; Prasad RB; Forsti A; Polakova V; Vodickova L; Novotny J; Hemminki K; Vodicka P
    Mutat Res; 2011 Mar; 721(1):74-80. PubMed ID: 21211571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.
    Mahid SS; Colliver DW; Crawford NP; Martini BD; Doll MA; Hein DW; Cobbs GA; Petras RE; Galandiuk S
    BMC Med Genet; 2007 May; 8():28. PubMed ID: 17537267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 haplotype determination in breast cancer.
    Weston A; Pan CF; Ksieski HB; Wallenstein S; Berkowitz GS; Tartter PI; Bleiweiss IJ; Brower ST; Senie RT; Wolff MS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):105-12. PubMed ID: 9037561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TP53 mutation and haplotype analysis of two large African American families.
    Hung J; Mims B; Lozano G; Strong L; Harvey C; Chen TT; Stastny V; Tomlinson G
    Hum Mutat; 1999; 14(3):216-21. PubMed ID: 10477429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma.
    Fan Y; Zhang X; Yang ZH; Sun XW; Li SN; Zhong L; Cheng X; Wang Y; Ma YR
    DNA Cell Biol; 2013 Oct; 32(10):594-600. PubMed ID: 23952692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study.
    Wedrén S; Lovmar L; Humphreys K; Magnusson C; Melhus H; Syvänen AC; Kindmark A; Landegren U; Fermér ML; Stiger F; Persson I; Baron J; Weiderpass E
    Breast Cancer Res; 2004; 6(4):R437-49. PubMed ID: 15217512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.
    Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K
    BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variations in the xenobiotic-metabolizing enzymes CYP1A1, CYP1A2, CYP2C9, CYP2C19 and susceptibility to colorectal cancer among Turkish people.
    Özhan G; Mutur M; Ercan G; Alpertunga B
    Genet Test Mol Biomarkers; 2014 Apr; 18(4):223-8. PubMed ID: 24527758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.